{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:51:07Z","timestamp":1790639467974,"version":"4.1.0"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,1]]},"abstract":"<jats:p>E-cigarettes and vaping products were first introduced in the United States around 2007, and quickly grew in popularity. By 2014, e-cigarettes had become the most commonly used tobacco product among youth in the United States. An e-cigarette, or vaping, product use\u2013associated lung injury (EVALI) outbreak was identified by the Centers for Disease Control and Prevention (CDC) in 2019, with many cases in the adolescent population. The CDC opened a national database of cases and launched a multistate investigation; reported cases reached a peak in September 2019. The CDC investigation found that a vaping liquid additive, vitamin E acetate, was strongly linked to the EVALI outbreak but determined that the decline in cases was likely multifactorial. Due to decreased cases and the identification of a potential cause of the outbreak, the CDC stopped collecting data on EVALI cases as of February 2020. However, e-cigarettes and vaping products have continued to be the most popular tobacco product among youth, though state and national regulations on these products have increased since 2016. While pediatric case series and studies have shown differences in clinical presentation and medical histories between pediatric and adult EVALI cases, the fact that cases are no longer tracked at a national level limits necessary information for pediatric clinicians and researchers. We describe the available literature on the diagnosis, pathophysiology, treatment, and outcomes of EVALI in the pediatric population, and provide clinical and public health recommendations to facilitate prevention and management of EVALI specific to pediatrics.<\/jats:p>","DOI":"10.1542\/peds.2023-063484","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T08:09:34Z","timestamp":1713341374000},"source":"Crossref","is-referenced-by-count":7,"title":["The Evolution of a Pediatric Public Health Crisis: E-cigarette or Vaping-Associated Lung Injury"],"prefix":"10.1542","volume":"153","author":[{"given":"Carrie K.","family":"Barker","sequence":"first","affiliation":[{"name":"aUniversity of Wisconsin, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Princy","family":"Ghera","sequence":"additional","affiliation":[{"name":"bUniversity of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Hsu","sequence":"additional","affiliation":[{"name":"cUniversity of South Dakota, Sioux Falls, South Dakota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"2024050102512446600_B1","article-title":"Surgeon general\u2019s advisory on e-cigarette use among youth","author":"Centers for Disease Control and Prevention"},{"issue":"45","key":"2024050102512446600_B2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.15585\/mmwr.mm6745a5","article-title":"Notes from the field: Use of electronic cigarettes and any tobacco product among middle and high school students\u2014United States, 2011\u20132018","volume":"67","author":"Cullen","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"2024050102512446600_B3","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1378\/chest.11-2443","article-title":"Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide","volume":"141","author":"Vardavas","year":"2012","journal-title":"Chest"},{"issue":"1","key":"2024050102512446600_B4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jemermed.2013.09.034","article-title":"Case report of electronic cigarettes possibly associated with eosinophilic pneumonitis in a previously healthy active-duty sailor","volume":"47","author":"Thota","year":"2014","journal-title":"J Emerg Med"},{"issue":"36","key":"2024050102512446600_B5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.15585\/mmwr.mm6836e2","article-title":"Severe pulmonary disease associated with electronic-cigarette-product use\u2014interim guidance","volume":"68","author":"Schier","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024050102512446600_B6","article-title":"Outbreak of lung injury associated with the use of e-cigarette, or vaping, products","author":"Centers for Disease Control and Prevention"},{"issue":"1","key":"2024050102512446600_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1513\/AnnalsATS.202209-796ST","article-title":"The e-cigarette or vaping product use-associated lung injury epidemic: pathogenesis, management, and future directions: an official American Thoracic Society workshop report","volume":"20","author":"Rebuli","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2024050102512446600_B8","article-title":"How FDA is regulating e-cigarettes","author":"Sharpless"},{"key":"2024050102512446600_B9","article-title":"Tobacco 21","author":"United States Food and Drug Administration"},{"issue":"40","key":"2024050102512446600_B10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.15585\/mmwr.mm7140a3","article-title":"Notes from the field: e-cigarette use among middle and high school students\u2014United States, 2022","volume":"71","author":"Cooper","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024050102512446600_B11","article-title":"Health alert: e-cigarette, or vaping, product use-associated lung injury (EVALI) cases during California\u2019s COVID-19 response","author":"California Department of Public Health"},{"issue":"7","key":"2024050102512446600_B12","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/ppul.25384","article-title":"E-cigarette and vaping product use-associated lung injury in the pediatric population: a critical review of the current literature","volume":"56","author":"Kaslow","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2024050102512446600_B13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpeds.2020.09.040","article-title":"Diagnosis and acute management of e-cigarette or vaping product use-associated injury in the pediatric population: a systematic review","volume":"228","author":"Gonsalves","year":"2021","journal-title":"J Pediatr"},{"issue":"7","key":"2024050102512446600_B14","doi-asserted-by":"crossref","first-page":"e200756","DOI":"10.1001\/jamapediatrics.2020.0756","article-title":"Demographics, substance use behaviors, and clinical characteristics of adolescents with e-cigarette, or vaping, product use-associated lung injury (EVALI) in the United States in 2019","volume":"174","author":"Adkins","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"5","key":"2024050102512446600_B15","doi-asserted-by":"crossref","first-page":"e20193408","DOI":"10.1542\/peds.2019-3408","article-title":"E-cigarette or vaping product use-associated lung injury (EVALI) without respiratory symptoms","volume":"145","author":"Matta","year":"2020","journal-title":"Pediatrics"},{"issue":"2","key":"2024050102512446600_B16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1148\/radiol.2020192778","article-title":"Pediatric chest radiographic and CT findings of electronic cigarette or vaping product use-associated lung injury (EVALI)","volume":"295","author":"Artunduaga","year":"2020","journal-title":"Radiology"},{"issue":"46","key":"2024050102512446600_B17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.15585\/mmwr.mm6846e2","article-title":"Update: Interim guidance for health care providers for managing patients with suspected e-cigarette, or vaping, product use-associated lung injury\u2014United States, November 2019","volume":"68","author":"Jatlaoui","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2024050102512446600_B18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/ppul.24729","article-title":"Case series: adolescent victims of the vaping public health crisis with pulmonary complications","volume":"55","author":"Kass","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"2024050102512446600_B19","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/ppul.24787","article-title":"Impaired lung function following e-cigarette or vaping product use associated lung injury in the first cohort of hospitalized adolescents","volume":"55","author":"Carroll","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"45","key":"2024050102512446600_B20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.15585\/mmwr.mm6845e2","article-title":"Evaluation of bronchoalveolar lavage fluid from patients in an outbreak of e-cigarette, or vaping product use-associated lung injury: 10 states, August-October 2019","volume":"68","author":"Blount","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"2024050102512446600_B21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa1916433","article-title":"Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI","volume":"382","author":"Blount","year":"2020","journal-title":"N Engl J Med"},{"key":"2024050102512446600_B22","article-title":"Lung injuries associated with use of vaping products","author":"US Food and Drug Administration"},{"issue":"4","key":"2024050102512446600_B23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.chest.2020.03.085","article-title":"Vaping-related acute parenchymal lung injury: a systematic review","volume":"158","author":"Jonas","year":"2020","journal-title":"Chest"},{"issue":"3","key":"2024050102512446600_B24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/toxics8030046","article-title":"Pulmonary toxicity and inflammatory response of e-cigarette vape cartridges containing medium-chain triglycerides oil and vitamin E acetate: implications in the pathogenesis of EVALI","volume":"8","author":"Muthumalage","year":"2020","journal-title":"Toxics"},{"issue":"2","key":"2024050102512446600_B25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/toxics8020025","article-title":"Chemical constituents involved in e-cigarette, or vaping product use-associated lung injury (EVALI)","volume":"8","author":"Muthumalage","year":"2020","journal-title":"Toxics"},{"issue":"41","key":"2024050102512446600_B26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.15585\/mmwr.mm6841e3","article-title":"Update: interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use-associated lung injury\u2014United States, October 2019","volume":"68","author":"Siegel","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"2024050102512446600_B27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s13181-020-00765-9","article-title":"E-cigarette, or vaping, product use associated lung injury (EVALI) with acute respiratory failure in three adolescent patients: a clinic timeline, treatment, and product analysis","volume":"16","author":"Billa","year":"2020","journal-title":"J Med Toxicol"},{"issue":"5152","key":"2024050102512446600_B28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.15585\/mmwr.mm685152e1","article-title":"Characteristics of patients experiencing rehospitalization or death after hospital discharge in a nationwide outbreak of e-cigaratte, or vaping, product use-associated lung injury\u2014United States, 2019","volume":"68","author":"Mikosz","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"2024050102512446600_B29","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ppul.24872","article-title":"The importance of anti-vaping vigilance-EVALI in seven adolescent pediatric patients in Northeast Ohio","volume":"55","author":"Corcoran","year":"2020","journal-title":"Pediatr Pulmonol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-063484\/1623550\/peds.2023-063484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-063484\/1623550\/peds.2023-063484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T02:51:39Z","timestamp":1714531899000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/153\/5\/e2023063484\/197109\/The-Evolution-of-a-Pediatric-Public-Health-Crisis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,17]]},"published-print":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2023-063484","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"article-number":"e2023063484"}}